CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,072,960
- in 74 filings, $341.3M under 10b5-1 plans
Net −$342,072,960. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −618 | $582.42 | $360K | 331,663 |
| 2026-11-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −980 | $583.64 | $572K | 330,683 |
| 2026-11-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −328 | $584.76 | $192K | 330,355 |
| 2026-11-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −795 | $585.56 | $466K | 329,560 |
| 2026-11-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −937 | $586.66 | $550K | 328,623 |
| 2026-11-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −620 | $587.96 | $365K | 328,003 |
| 2026-11-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −360 | $589.15 | $212K | 327,643 |
| 2026-11-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,040 | $589.95 | $1.2M | 325,603 |
| 2026-11-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −960 | $590.95 | $567K | 324,643 |
| 2026-11-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −120 | $592.20 | $71K | 324,523 |
| 2026-11-10 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $592.93 | $47K | 324,443 |
| 2026-11-10 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 52,910 | ||
| 2026-11-09 | PATUSKY CHRISTOPHER Director | Option exercise | +1,210 | $132.30 | $160K | 3,350 |
| 2026-11-09 | PATUSKY CHRISTOPHER Director | Sale | −1,210 | $580.00 | $702K | 2,140 |
| 2026-11-09 | PATUSKY CHRISTOPHER Director | Option exercise · Stock Option | −1,210 | 3,000 | ||
| 2026-11-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −494 | $583.80 | $288K | 325,563 |
| 2026-11-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −840 | $584.70 | $491K | 324,723 |
| 2026-11-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −280 | $585.63 | $164K | 324,443 |
| 2026-11-09 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-11-09 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −80 | $556.52 | $45K | 333,863 |
Page 2 of 64 · 1,267 trades